Relationship between the prevalence of anti-glutamic acid decarboxylase autoantibodies and duration of type 1 diabetes mellitus in Brazilian patients

Rodacki, M; Zajdenverg, L; Albernaz, M. S; Bencke-Gonçalves, M. R; Milech, A; Oliveira, J. E. P.
Braz. j. med. biol. res ; 37(11): 1645-1650, Nov. 2004.
Artículo en Inglés | LILACS | ID: lil-385869

Documentos relacionados

  1. TCR<sup>+</sup>/BCR<sup>+</sup> dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes.
  2. Leveraging type 1 diabetes human genetic and genomic data in the T1D knowledge portal.
  3. MHC-II heterozygosity limits type 1 diabetes susceptibility through negative selection.
  4. A reply to "TCR+/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes".
  5. Th2 cell clonal expansion at diagnosis in human type 1 diabetes.
  6. Clinical Translation of Bio-Artificial Pancreas Therapies: Ethical, Legal and Psychosocial Interdisciplinary Considerations and Key Recommendations.
  7. Poor glycemic control impairs oral health in children with type 1 diabetes mellitus - a systematic review and meta-analysis.
  8. Circulating circular RNAs profiles associated with type 1 diabetes.
  9. Advances in Immunotherapeutic Approaches to Type 1 Diabetes.
  10. The impact of stigma on the management of type 1 diabetes: A systematic review.